Beddow Capital Management Inc Abb Vie Inc. Transaction History

Beddow Capital Management Inc

$244 Million
Q3 2024

A detailed history of Beddow Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Beddow Capital Management Inc holds 35,925 shares of ABBV stock, worth $6.52 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares

35,925

Previous 44,496 19.26%

Holding current value

$6.52 Million

Previous $7.63 Million 7.05%

% of portfolio

2.91%

Previous 3.34%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $1.4 Million - $1.71 Million	-8,571 Reduced 19.26%	35,925 $7.09 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $23,218 - $27,114	-150 Reduced 0.34%	44,496 $7.63 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $1.46 Million - $1.66 Million	-9,117 Reduced 16.96%	44,646 $8.13 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $61,920 - $69,736	450 Added 0.84%	53,763 $8.33 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $119,830 - $138,721	-897 Reduced 1.65%	53,313 $7.95 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $57,641 - $71,731	-435 Reduced 0.8%	54,210 $7.3 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $253,067 - $291,445	-1,750 Reduced 3.1%	54,645 $8.71 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $425,303 - $510,050	3,075 Added 5.77%	56,395 $9.11 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $251,643 - $288,618	1,875 Added 3.64%	53,320 $7.16 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $739,088 - $917,000	-5,600 Reduced 9.82%	51,445 $8.34 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $1.48 Million - $1.88 Million	13,800 Added 31.91%	57,045 $7.72 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $602,330 - $683,735	5,661 Added 15.06%	43,245 $4.67 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $83,536 - $93,064	794 Added 2.16%	37,584 $4.23 Million
Q1 2021 Apr 08, 2021	BUY	$102.3 - $112.62 $82,863 - $91,222	810 Added 2.25%	36,790 $3.98 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $20,122 - $27,167	250 Added 0.7%	35,980 $3.86 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $89,775 - $105,367	-1,045 Reduced 2.84%	35,730 $3.13 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $372,352 - $498,263	-5,075 Reduced 12.13%	36,775 $3.61 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $108,037 - $163,798	1,675 Added 4.17%	41,850 $3.19 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $73,067 - $91,423	1,013 Added 2.59%	40,175 $3.56 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $410,629 - $493,694	6,520 Added 19.97%	39,162 $2.97 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $1.1 Million - $1.4 Million	16,675 Added 104.43%	32,642 $2.37 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $902,152 - $1.06 Million	11,695 Added 273.76%	15,967 $1.29 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $332,575 - $410,154	4,272 New	4,272 $394,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beddow Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Beddow Capital Management Inc with notifications on news.

Account

Beddow Capital Management Inc Abb Vie Inc. Transaction History